QuidelOrtho
Troy Gilliam is a seasoned professional in the life sciences industry, currently serving as Associate Director of Portfolio Management at QuidelOrtho since February 2017, where responsibilities include managing an IVD and RUO immunoassay product portfolio and setting marketing strategies. Prior to this role, Troy held positions such as Sales Marketing Manager at GenWay Biotech, overseeing catalog products and global marketing strategies, and Director of Sales & Marketing at Abgent, where duties involved managing the yearly global marketing strategy and budgeting. Troy's early career includes a New Product Commercialization internship at Biogen Idec, contributing to oncology product development plans, and research experience at Seattle Biomedical Research Institute. Academic qualifications include an MBA in Strategy, Marketing, and Product Development from the Rady School of Management at UC San Diego and a BS in Microbiology from the University of Washington.
This person is not in any teams
This person is not in any offices
QuidelOrtho
15 followers
At QuidelOrtho, we’re changing lives one test at a time. With precision and passion, we give people the clarity to create better health outcomes. Our focus is providing the intelligence people need in the moments they need them most. To get there, we imagine, invent, push and pursue for more accurate and reliable diagnostics, faster. Since day one, we’ve provided breakthrough solutions to healthcare professionals. Now, we’re creating a clearer picture of health for more people globally. From home to hospital, lab to clinic, we’re helping people everywhere move forward – going the extra mile for everyone we serve. Together, we're advancing diagnostics to power a healthier future.